School kicks off today for many kids, but as we report in "The Tan Sheet" class has already been in session for many in the dietary supplement and OTC industries. This week's issue takes a look at why constant education of retailers is essential to keeping them on-message and in compliance with regard to supplement health claims.
In Social Studies class, USANA Health Sciences gets an "A" from analysts on its Chinese expansion project, making inroads into the market through a strategic acquisition. We explore how the nutritional direct-seller expects to benefit from its purchase of Chinese supplement and infant formula firm BabyCare.
In Science class, FDA's Science Board evaluates the agency's nanotechnology efforts and finds room for improvement. FDA's fiscal 2011 budgest request of $7.3 million for nanotech, used in an increasing number of consumer health products, is insufficient, and FDA should take a leadership role in the emerging field, members of the advisory panel said at an Aug. 16 meeting.
And finally, because some students are bound to fall asleep at their desk, Johnson & Johnson/McNeil hopes to eventually add more explicit sleep-aid language to its Tylenol PM labeling. Our Aug. 23 issue explains how the firm is seeking FDA review of clinical data that could spur an OTC monograph amendment, which would then allow McNeil to make label claims comparable to those made for Pfizer's Advil PM.
(Everything you need to know about OTCs and supplements, you'll learn in "The Tan Sheet." Click here to get your first issue free.)
TOP STORIES
McNeil Dreams Of Tylenol PM Sleep-Aid Indication
McNeil Consumer Healthcare says recent clinical data support a sleep-aid/pain relief indication for the ingredient combination in Tylenol PM.
USANA Acquires BabyCare For Faster Route To China
Multi-level dietary supplement marketer USANA Health Sciences chooses a faster route over the "arduous" licensing approach to enter China by acquiring nutritional product firm BabyCare Ltd.
Retailer Training Crucial To Keeping Supplement Claims Compliant
Dietary supplement manufacturers bear the burden of ensuring businesses selling their products comply with claims regulations, experts say.
- Matrixx Trims Zicam Litigation Load To Focus on Personal Injury Claims
- $100 Million Acai Case Could Be Tip Of FTC's Enforcement Iceberg
DIETARY SUPPLEMENTS
- Vitacost.com Turns To Vitamin Shoppe Founder To Right Ship
OTCs
- Probe of Acetaminophen/Asthma Link Causality Urgently Needed, Say Authors
- Novartis Weighs Sweetening Buyout Offer As Alcon Shareholders Fight Back
- Dermatologists Find No Evidence That Vitamin A Sunscreens Cause Cancer
FDA
- Chart: Science Board Makes Recommendations To CFSAN
- FDA Science Board Recommends Larger Nanotech Program Budget
PEOPLE
- People In Brief
IN BRIEF
- CSPI drops Coca-Cola weight loss suit
- Weight-loss, male enhancement drugs recalled
- NBTY supplements contain undeclared soy
- Tiger Balm marketer earns FDA warning
- J&J reorganizes QC functions
- Lotus expands OTC business
- Feinstein to offer limited BPA amendment
- Atrium integrates Trophic Canada
- Optigenex expands Promethean partnership
- Energy drinks thirst for users, Mintel says
- Dan Schiff (d.schiff@elsevier.com)
